BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26032184)

  • 41. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multiprobe fluorescence in situ hybridization panel in detection of the common cytogenetic abnormalities of acute myeloid leukemia].
    Xu LL; Liu XL; Du QF; Song LL; Cao R; Wei YQ; Xu N; Zhang JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):324-6. PubMed ID: 21638933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and experimental study of 38 cases with trisomy 8].
    Xu WL; Jin J; Chen ZM; Lou JY; Yu YB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):528-31. PubMed ID: 14669224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Jumping translocations in hematological malignancies: a cytogenetic study of five cases.
    Manola KN; Georgakakos VN; Stavropoulou C; Spyridonidis A; Angelopoulou MK; Vlachadami I; Katsigiannis A; Roussou P; Pantelias GE; Sambani C
    Cancer Genet Cytogenet; 2008 Dec; 187(2):85-94. PubMed ID: 19027489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
    Bacher U; Schnittger S; Grüneisen A; Haferlach T; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2009 Jan; 188(2):108-11. PubMed ID: 19100515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
    Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
    Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isochromosome 5p and related anomalies: a novel recurrent chromosome abnormality in myeloid disorders.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Guéganic N; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Jul; 200(2):134-9. PubMed ID: 20620596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
    Guo Y; Xue Y; Xie X; Wu D; Li J; Lu D; Jiang F; Geng M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):72-5. PubMed ID: 10751523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
    Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
    Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.
    Cortes JE; Kantarjian H; O'Brien S; Keating M; Pierce S; Freireich EJ; Estey E
    Leukemia; 1995 Jan; 9(1):115-7. PubMed ID: 7845005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
    Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
    Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.
    Park TS; Cheong JW; Song J; Choi JR
    Leuk Res; 2009 Jul; 33(7):1001-4. PubMed ID: 19155067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A clinical and laboratory study of 11 cases of t(6;11)(q27;q23) acute leukemia].
    Pan JL; Xue YQ; Jiang HY; Li TY; Wang Y; Qian J; Wu YF; Wu TQ
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):920-3. PubMed ID: 15730738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
    Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
    El-Menoufy MAM; Mourad ZI; Farahat NM
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.